Documentos relacionados

1. Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer.
2. Androgen deprivation therapy: indications, methods of utilization, side effects and their management.
3. Reply to letter to editor regarding: LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer.
4. Re: Osteoporosis and Prostate Cancer; A 24-Month Prospective Observational Study during Androgen Deprivation Therapy.
5. Impact of Asian Race on Prognosis in De Novo Metastatic Prostate Cancer.
6. Cardiovascular Disease and Androgen Axis-Targeted Drugs for Prostate Cancer.
7. Re: Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy: Effects of Androgen-Deprivation Therapy.
8. Quality of life in low-income men after surgical castration for metastatic prostate cancer.
9. Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy.
10. Current and emerging gonadotropin-releasing hormone (GnRH) antagonists for the treatment of prostate cancer.